血液&骨髄腫治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE1918)
◆英語タイトル:Global Blood and Bone Marrow Cancer Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE1918
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、血液&骨髄腫治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(化学療法、免疫療法、幹細胞移植、放射線療法)、用途別市場規模(多発性骨髄腫、白血病、リンパ腫、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・血液&骨髄腫治療の市場動向
・企業の競争状況、市場シェア
・血液&骨髄腫治療の種類別市場規模(化学療法、免疫療法、幹細胞移植、放射線療法)
・血液&骨髄腫治療の用途別市場規模(多発性骨髄腫、白血病、リンパ腫、その他)
・血液&骨髄腫治療の北米市場規模2016-2027(アメリカ、カナダ)
・血液&骨髄腫治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・血液&骨髄腫治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・血液&骨髄腫治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・血液&骨髄腫治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AstraZeneca, Plc.、Celgene, Inc.、Bristol Myers Squibb & Company、Eli Lilly & Company、Johnson & Johnson Company、F.Hoffman La-Roche Ltd.、Merck & Co., Inc.、Novartis AG、Pfizer, Inc.、Varian Medical Systems, Inc.)
・結論
【レポートの概要】

Blood cancer begins in the bone marrow which is the integral source of stem cells which later are differentiated in different types of blood cells in the human body.

Market Analysis and Insights: Global Blood and Bone Marrow Cancer Treatment Market
The global Blood and Bone Marrow Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood and Bone Marrow Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood and Bone Marrow Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood and Bone Marrow Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood and Bone Marrow Cancer Treatment market.

Global Blood and Bone Marrow Cancer Treatment Scope and Market Size
Blood and Bone Marrow Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood and Bone Marrow Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Immunotherapy
Stem Cell Transplant
Radiotherapy

Segment by Application
Multiple Myeloma
Leukemia
Lymphoma
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca, Plc.
Celgene, Inc.
Bristol Myers Squibb & Company
Eli Lilly & Company
Johnson & Johnson Company
F.Hoffman La-Roche Ltd.
Merck & Co., Inc.
Novartis AG
Pfizer, Inc.
Varian Medical Systems, Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood and Bone Marrow Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Stem Cell Transplant
1.2.5 Radiotherapy
1.3 Market by Application
1.3.1 Global Blood and Bone Marrow Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Multiple Myeloma
1.3.3 Leukemia
1.3.4 Lymphoma
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Blood and Bone Marrow Cancer Treatment Market Perspective (2016-2027)
2.2 Blood and Bone Marrow Cancer Treatment Growth Trends by Regions
2.2.1 Blood and Bone Marrow Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Blood and Bone Marrow Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Blood and Bone Marrow Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Blood and Bone Marrow Cancer Treatment Industry Dynamic
2.3.1 Blood and Bone Marrow Cancer Treatment Market Trends
2.3.2 Blood and Bone Marrow Cancer Treatment Market Drivers
2.3.3 Blood and Bone Marrow Cancer Treatment Market Challenges
2.3.4 Blood and Bone Marrow Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Blood and Bone Marrow Cancer Treatment Players by Revenue
3.1.1 Global Top Blood and Bone Marrow Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Blood and Bone Marrow Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Blood and Bone Marrow Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Blood and Bone Marrow Cancer Treatment Revenue
3.4 Global Blood and Bone Marrow Cancer Treatment Market Concentration Ratio
3.4.1 Global Blood and Bone Marrow Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood and Bone Marrow Cancer Treatment Revenue in 2020
3.5 Blood and Bone Marrow Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Blood and Bone Marrow Cancer Treatment Product Solution and Service
3.7 Date of Enter into Blood and Bone Marrow Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Blood and Bone Marrow Cancer Treatment Breakdown Data by Type
4.1 Global Blood and Bone Marrow Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Blood and Bone Marrow Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Blood and Bone Marrow Cancer Treatment Breakdown Data by Application
5.1 Global Blood and Bone Marrow Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Blood and Bone Marrow Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Blood and Bone Marrow Cancer Treatment Market Size (2016-2027)
6.2 North America Blood and Bone Marrow Cancer Treatment Market Size by Type
6.2.1 North America Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Blood and Bone Marrow Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Blood and Bone Marrow Cancer Treatment Market Size by Application
6.3.1 North America Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Blood and Bone Marrow Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Blood and Bone Marrow Cancer Treatment Market Size by Country
6.4.1 North America Blood and Bone Marrow Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Blood and Bone Marrow Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Blood and Bone Marrow Cancer Treatment Market Size (2016-2027)
7.2 Europe Blood and Bone Marrow Cancer Treatment Market Size by Type
7.2.1 Europe Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Blood and Bone Marrow Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Blood and Bone Marrow Cancer Treatment Market Size by Application
7.3.1 Europe Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Blood and Bone Marrow Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Blood and Bone Marrow Cancer Treatment Market Size by Country
7.4.1 Europe Blood and Bone Marrow Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Blood and Bone Marrow Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Blood and Bone Marrow Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Blood and Bone Marrow Cancer Treatment Market Size (2016-2027)
9.2 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Type
9.2.1 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Application
9.3.1 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Country
9.4.1 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Blood and Bone Marrow Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Blood and Bone Marrow Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca, Plc.
11.1.1 AstraZeneca, Plc. Company Details
11.1.2 AstraZeneca, Plc. Business Overview
11.1.3 AstraZeneca, Plc. Blood and Bone Marrow Cancer Treatment Introduction
11.1.4 AstraZeneca, Plc. Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.1.5 AstraZeneca, Plc. Recent Development
11.2 Celgene, Inc.
11.2.1 Celgene, Inc. Company Details
11.2.2 Celgene, Inc. Business Overview
11.2.3 Celgene, Inc. Blood and Bone Marrow Cancer Treatment Introduction
11.2.4 Celgene, Inc. Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.2.5 Celgene, Inc. Recent Development
11.3 Bristol Myers Squibb & Company
11.3.1 Bristol Myers Squibb & Company Company Details
11.3.2 Bristol Myers Squibb & Company Business Overview
11.3.3 Bristol Myers Squibb & Company Blood and Bone Marrow Cancer Treatment Introduction
11.3.4 Bristol Myers Squibb & Company Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.3.5 Bristol Myers Squibb & Company Recent Development
11.4 Eli Lilly & Company
11.4.1 Eli Lilly & Company Company Details
11.4.2 Eli Lilly & Company Business Overview
11.4.3 Eli Lilly & Company Blood and Bone Marrow Cancer Treatment Introduction
11.4.4 Eli Lilly & Company Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.4.5 Eli Lilly & Company Recent Development
11.5 Johnson & Johnson Company
11.5.1 Johnson & Johnson Company Company Details
11.5.2 Johnson & Johnson Company Business Overview
11.5.3 Johnson & Johnson Company Blood and Bone Marrow Cancer Treatment Introduction
11.5.4 Johnson & Johnson Company Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Company Recent Development
11.6 F.Hoffman La-Roche Ltd.
11.6.1 F.Hoffman La-Roche Ltd. Company Details
11.6.2 F.Hoffman La-Roche Ltd. Business Overview
11.6.3 F.Hoffman La-Roche Ltd. Blood and Bone Marrow Cancer Treatment Introduction
11.6.4 F.Hoffman La-Roche Ltd. Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.6.5 F.Hoffman La-Roche Ltd. Recent Development
11.7 Merck & Co., Inc.
11.7.1 Merck & Co., Inc. Company Details
11.7.2 Merck & Co., Inc. Business Overview
11.7.3 Merck & Co., Inc. Blood and Bone Marrow Cancer Treatment Introduction
11.7.4 Merck & Co., Inc. Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.7.5 Merck & Co., Inc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Blood and Bone Marrow Cancer Treatment Introduction
11.8.4 Novartis AG Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 Pfizer, Inc.
11.9.1 Pfizer, Inc. Company Details
11.9.2 Pfizer, Inc. Business Overview
11.9.3 Pfizer, Inc. Blood and Bone Marrow Cancer Treatment Introduction
11.9.4 Pfizer, Inc. Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.9.5 Pfizer, Inc. Recent Development
11.10 Varian Medical Systems, Inc.
11.10.1 Varian Medical Systems, Inc. Company Details
11.10.2 Varian Medical Systems, Inc. Business Overview
11.10.3 Varian Medical Systems, Inc. Blood and Bone Marrow Cancer Treatment Introduction
11.10.4 Varian Medical Systems, Inc. Revenue in Blood and Bone Marrow Cancer Treatment Business (2016-2021)
11.10.5 Varian Medical Systems, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 血液&骨髄腫治療の世界市場規模・現状・予測2021年-2027年(Global Blood and Bone Marrow Cancer Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。